In terms of market performance, Monopar Therapeutics Inc had a somewhat regular. The highest value for the stock in the past year was $8.65 on 10/24/24, while the lowest value was $1.37 on 11/27/23.
52-week price history of MNPR Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Monopar Therapeutics Inc’s current trading price is 50.06% away from its 52-week high, while its distance from the 52-week low is 847.79%. The stock’s price range for this period has remained between $1.37 and $8.65. The Healthcare sector company’s shares managed to surpass a trading volume of around 2.62 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.81 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Monopar Therapeutics Inc (MNPR) has experienced a quarterly rise of 260.56% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 45.69M and boasts a workforce of 10 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.88, with a change in price of +10.02. Similarly, Monopar Therapeutics Inc recorded 556,687 in trading volume during the last 100 days, posting a change of +260.31%.
MNPR Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for MNPR stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
MNPR Stock Stochastic Average
As of today, the raw stochastic average of Monopar Therapeutics Inc over the past 50 days is 100.00%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 100.00%. Additionally, the Stochastic %K and %D values for the company were 47.26% and 37.72%, respectively, over the past 20 days.
MNPR Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price gain of 663.08% this year. Over the last six months, there has been a weaker performance of 313.71%. The price of MNPR fallen by 151.06% during the last 30 days period. For the last 5-days stocks have improved 127.32%.
